Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Disease-specific tools better assess alopecia areata's impact on quality of life.

Intralesional corticosteroids effectively treat localized alopecia areata, often sparing white hairs.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

The document concludes that hair loss has many causes and treatments vary, including medication for pattern baldness and addressing underlying issues for other types.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Some new treatments for children's skin conditions are effective, but risks must be weighed.

New hair loss treatments could be improved by using combined biological markers.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Low-dose minoxidil effectively enhances facial hair with minimal side effects.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Carcinosin, a homeopathic remedy, helped a young girl with alopecia areata regrow hair and reduce psychological symptoms.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.